Here’s whether TG Therapeutics, Inc. (TGTX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.00% over 10 days); strong 1-year return of +32.5%; 3-month momentum positive (+72.1%). Concerns: RSI 80 — overbought, elevated pullback risk. Currently 1.8% off its 52-week high. Score: +5/7.
TGTX is in a confirmed uptrend, trading above both its 50-day ($38.32) and 200-day ($33.20) moving averages. With an RSI of 80.2, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +32.5% compares to +22.9% for SPY (beat the market by 9.7%).
$10,000 invested 1 year ago→ $13,251 today
vs. S&P 500 (SPY) — same period beat market by 9.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($33.20)
✓Above 50-day MA ($38.32)
!RSI(14) neutral zone (30–70) — currently 80.2
✓Positive return (+32.5%)
✓Within 10% of period high (−1.8%)
Period Range $49.52
$25.28$50.41
RSI (14) 80.2
0 · OversoldOverbought · 100
Key Metrics
Price$49.52
Period Return+32.5%
Period High$50.41
Period Low$25.28
Drawdown−1.8%
MA-50$38.32
MA-200$33.20
RSI (14)80.2
Avg Volume (30d)2.3M
vs. SPYbeat by 9.7%
Return Rank#462 of 1246
Trend Signals
Price is above the 200-day moving average ($33.20)